Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update

Overview of attention for article published in Journal of Clinical Oncology, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 91 X users

patent: 2 patents
facebook: 1 Facebook page
guideline: 4 clinical guideline sources

Readers on

mendeley: 292 Mendeley

So far, Altmetric has seen 8 Guidelines that reference this research output.

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management

Clinical guideline published by Taiwan Breast Cancer Society (TIBCS) on 01 Jun 2026

The Taiwan Breast Cancer Society (TBCS) is a non-profit medical organization established in 1997 to improve the quality of breast cancer care, research, and clinical treatment standards in Taiwan

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025

Clinical guideline published by Breast Cancer Canada on 09 Feb 2026

Breast Cancer Canada is a national charitable organization dedicated to saving lives through breast cancer research, education, and advocacy.

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

Clinical guideline published by ABC Global Alliance on 28 May 2024

The ABC Global Alliance is dedicated to improving the lives of individuals with advanced breast cancer worldwide. They focus on raising awareness, providing resources, and fostering collaboration among healthcare professionals and patients to enhance care and drive change in treatment practices.

Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline

Clinical guideline published by American Society of Clinical Oncology (ASCO) on 10 Jan 2024

The American Society of Clinical Oncology (ASCO) is a leading organization dedicated to advancing cancer care through research, education, and clinical practice. ASCO provides evidence-based clinical guidelines to support oncologists in delivering optimal patient care and improving outcomes.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 4 additional posts.